Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/17/2025

Smoking Cessation in Inflammatory Bowel Disease

Introduction to Smoking Effects on IBD

  • Smoking has opposite effects on the two major forms of IBD: it worsens Crohn's disease outcomes while appearing protective in ulcerative colitis, making smoking cessation essential for Crohn's disease patients but potentially problematic for those with ulcerative colitis 1
  • Smoking is more common in patients diagnosed with Crohn's disease, particularly in those diagnosed after age 40 (47% prevalence vs. 27% in background population) 1

Effects of Smoking on Crohn's Disease

  • Continued smoking results in worse disease course compared to non-smokers or those who quit, higher risk of disease flares, increased incidence of surgery, worse outcomes after surgery (2.5-fold increase in risk of repeat surgery), and 2-fold increased risk of clinical recurrence 1
  • Even passive smoking and light smoking (<10 cigarettes/day) are as harmful as heavy smoking 1
  • Smoking effects are more pronounced in women than men with Crohn's disease 1
  • Smoking increases surgical complications for all colorectal surgeries 1

Effects of Smoking on Ulcerative Colitis

  • UC is more common in non-smokers 1
  • UC is more likely to arise in those who recently quit smoking (highest risk period: 2-5 years after stopping) 1
  • UC patients who smoke experience reduced colectomy rates, less primary sclerosing cholangitis, less back-wash ileitis, less extensive disease with higher cigarette consumption, and reduced need for therapy 1
  • UC patients who quit smoking have a significantly worse disease course than those who continue, with increased need for corticosteroids and azathioprine, and higher hospitalization rates 1

Smoking Cessation Recommendations

  • All Crohn's disease patients who smoke should be strongly encouraged to stop smoking, as this significantly improves disease outcomes and reduces complications 1
  • Benefits of quitting accrue at any stage of Crohn's disease 1
  • Active smoking cessation measures should be employed, including behavioral therapy (e.g., cognitive behavioral therapy) and pharmacotherapy (nicotine replacement, bupropion, varenicline) 1
  • UC patients who smoke should still be encouraged to stop for general health benefits, with warnings about the increased risk of disease flare after smoking cessation, and potential medication adjustments to control disease after smoking cessation 1

Clinical Approach to Smoking Cessation in IBD

  • Assessment: Identify all IBD patients who smoke 1
  • Education: Explain disease-specific effects of smoking 1
  • Intervention: Refer to smoking cessation services, combine behavioral therapy with pharmacotherapy, and consider setting up dedicated smoking cessation services for IBD patients (cost-effective due to reduced disease management costs) 1
  • Follow-up: Monitor disease activity closely after smoking cessation, especially in UC patients 1